Importer of Controlled Substances Application: VHG Labs DBA LGC Standards, 10357-10358 [2021-03381]
Download as PDF
<![CDATA[
10357
Federal Register / Vol. 86, No. 32 / Friday, February 19, 2021 / Notices
responsibility. See supra II.C; RD, at 21
(citing Arvinder Singh, M.D., 81 FR
8247, 8249–51 (2016)); Stein, 84 FR
46973. Additionally, Respondent plead
nolo contendere instead of guilty to the
charge of offering unlawful Medi-Cal
remuneration. GX 3. ‘‘In general,
however, a plea of nolo contendere is
inconsistent with the acceptance of
responsibility.’’ RD, at 21 (citing United
States v. Gordon, 979 F. Supp. 337, 342
(E.D. Pa. 1997) (internal citations
omitted)). Finding that a respondent has
failed to accept responsibility is
warranted where, as here, the
respondent pled nolo contendere and
minimized his role in the crime. See
Jeffery M. Freesemann, M.D., 76 FR
60873, 60888 (2011); see also RD, at 22.
Respondent must convince the
Administrator that his acceptance of
responsibility and remorse are
sufficiently credible to demonstrate that
the misconduct will not recur.
Respondent, in his opening statement,
argued that his testimony would show
‘‘his genuine remorse . . . .’’ Tr. 14. But
the record indicates that Respondent
was not remorseful for what he did;
instead that he regretted the
consequences that flowed from his
conviction.14 Id. at 31, 39, 68. This lack
of remorse goes hand-in-hand with
Respondent’s failure to accept
responsibility and further supports the
revocation of his registration.
In sanction determinations, the
Agency has historically considered its
interest in deterring similar acts, both
with respect to the respondent in a
particular case and the community of
registrants. See Joseph Gaudio, M.D., 74
FR 10083, 10095 (2009); Singh, 81 FR at
8248. In this case, the Respondent knew
at the time that he committed the crime
that his actions were illegal—he even
told Mr. Gonzales that the actions were
illegal and advised him not to tell
anyone. Deterring such deceit and
knowing criminal behavior both in
Respondent and the general registrant
community is relevant to ensuring
compliance with the CSA. Although I
would not characterize Respondent’s
underlying crime as particularly
egregious, Respondent has not
convinced me that he will not repeat
such deceitful behavior in using his
CSA registration.
Respondent has argued, among other
things, that he can be entrusted with a
registration because he has seen over
15,000 patients in twenty years and has
never had any issues with prescribing,
he has never had a malpractice
complaint, he is very mindful of the
opioid crisis, and he has satisfied the
terms of his probation. Tr. 13–14, 37, 74.
Even assuming, arguendo, all of this to
be true, Respondent needed to present
evidence of a credible and persuasive
acceptance of responsibility.
Respondent has not.
Based on Respondent’s failure to
accept responsibility for his criminal
misconduct and lack of demonstrated
remorse, I cannot find that Respondent
can be entrusted with a DEA
registration; and therefore, I find that
revocation is the appropriate sanction
I will therefore order that
Respondent’s registration be revoked as
contained in the Order below.
Order
Pursuant to 28 CFR 0.100(b) and the
authority vested in me by 21 U.S.C.
824(a), I hereby revoke DEA Certificate
of Registration No. BA6641472 issued to
Ibrahim Al-Qawaqneh, D.D.S. This
Order is effective March 22, 2021.
D. Christopher Evans,
Acting Administrator.
ACTION:
Notice of application.
VHG Labs DBA LGC
Standards has applied to be registered
as an importer of basic class(es) of
controlled substance(s). Refer to
Supplemental Information listed below
for further drug information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 22, 2021. Such persons
may also file a written request for a
hearing on the application on or before
March 22, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on February 2, 2021, VHG
Labs DBA LGC Standards, 3 Perimeter
Road, Manchester, New Hampshire
03103, applied to be registered as an
importer of the following basic class(es)
of controlled substance(s):
SUPPLEMENTARY INFORMATION:
[FR Doc. 2021–03360 Filed 2–18–21; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–793]
Importer of Controlled Substances
Application: VHG Labs DBA LGC
Standards
Drug Enforcement
Administration, Justice.
AGENCY:
tkelley on DSKBCP9HB2PROD with NOTICES
Controlled substance
Drug code
Cathinone ........................................................................................................................................................................
Methcathinone .................................................................................................................................................................
Naphyrone .......................................................................................................................................................................
N-Ethylamphetamine .......................................................................................................................................................
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ...................................................................................................
SR-18 (Also known as RCS-–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ...............................................
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide ..............................................................
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ...................................................................................................
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ......................................................................
14 For example, Respondent testified ‘‘I really
suffered going through these things—something I
didn’t do . . . [I] lost most—most of my patients,
VerDate Sep<11>2014
21:07 Feb 18, 2021
Jkt 253001
lost a lot of PPO insurances. I have to pay a lot of
employees, and so many things for something that
happened—someone faking like, you know,
PO 00000
Frm 00125
Fmt 4703
Sfmt 4703
1235
1237
1258
1475
6250
7008
7048
7081
7104
Schedule
I
I
I
I
I
I
I
I
I
accusing you of doing something, but there’s no 100
percent proof.’’ Tr. 68.
E:\FR\FM\19FEN1.SGM
19FEN1
10358
Federal Register / Vol. 86, No. 32 / Friday, February 19, 2021 / Notices
Controlled substance
Drug code
tkelley on DSKBCP9HB2PROD with NOTICES
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ..............................................................................
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ......................................................................................................
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ..................................................................
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ......................................................................................................
Ibogaine ...........................................................................................................................................................................
Lysergic acid diethylamide ..............................................................................................................................................
Marihuana Extract ...........................................................................................................................................................
Marihuana ........................................................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
Mescaline .........................................................................................................................................................................
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ......................................................................................................
3,4-Methylenedioxymethamphetamine ............................................................................................................................
5-Methoxy-N–N-dimethyltryptamine ................................................................................................................................
Psilocyn ...........................................................................................................................................................................
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) .....................................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) .......................................................................................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ......................................................................................................
Butylone ...........................................................................................................................................................................
Pentylone .........................................................................................................................................................................
Codeine-N-oxide ..............................................................................................................................................................
Desomorphine .................................................................................................................................................................
Dihydromorphine .............................................................................................................................................................
Heroin ..............................................................................................................................................................................
Morphine-N-oxide ............................................................................................................................................................
Normorphine ....................................................................................................................................................................
Tilidine .............................................................................................................................................................................
Alpha-methylfentanyl .......................................................................................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ...............................................................................
Methamphetamine ...........................................................................................................................................................
Phenmetrazine .................................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Amobarbital ......................................................................................................................................................................
Pentobarbital ....................................................................................................................................................................
Secobarbital .....................................................................................................................................................................
Glutethimide .....................................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) .....................................................................................................................
Norfentanyl ......................................................................................................................................................................
Phenylacetone .................................................................................................................................................................
Codeine ...........................................................................................................................................................................
Dihydrocodeine ................................................................................................................................................................
Diphenoxylate ..................................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Ethylmorphine ..................................................................................................................................................................
Hydrocodone ...................................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Meperidine intermediate-B ..............................................................................................................................................
Meperidine intermediate-C ..............................................................................................................................................
Methadone intermediate ..................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..............................................................................................................
Morphine ..........................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
14-Hydroxmorphone ........................................................................................................................................................
Noroxymorphone .............................................................................................................................................................
Sufentanil .........................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
The company plans to import the
listed controlled substances for sale to
research facilities for drug testing and
analysis. In reference to drug codes 7360
(Marihuana) and 7370
(Tetrahydrocannabinols) the company
plans to import a synthetic cannabidiol
and a synthetic tetrahydrocannabinol.
No other activities for these drug codes
are authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
VerDate Sep<11>2014
21:07 Feb 18, 2021
Jkt 253001
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–03381 Filed 2–18–21; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00126
Fmt 4703
Sfmt 4703
7118
7122
7144
7203
7260
7315
7350
7360
7370
7381
7398
7405
7431
7438
7498
7535
7540
7541
7542
9053
9055
9145
9200
9307
9313
9750
9814
9821
1105
1631
1724
2125
2270
2315
2550
7471
8333
8366
8501
9050
9120
9170
9180
9190
9193
9220
9230
9233
9234
9254
9273
9300
9333
9665
9668
9740
9801
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[Notice: (21–009)]
NASA Astrophysics Advisory
Committee; Meeting
National Aeronautics and
Space Administration.
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, Public
SUMMARY:
E:\FR\FM\19FEN1.SGM
19FEN1
]]>Agencies
[Federal Register Volume 86, Number 32 (Friday, February 19, 2021)]
[Notices]
[Pages 10357-10358]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03381]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-793]
Importer of Controlled Substances Application: VHG Labs DBA LGC
Standards
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: VHG Labs DBA LGC Standards has applied to be registered as an
importer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before March 22, 2021.
Such persons may also file a written request for a hearing on the
application on or before March 22, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on February 2, 2021, VHG Labs DBA LGC Standards, 3
Perimeter Road, Manchester, New Hampshire 03103, applied to be
registered as an importer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Cathinone................................ 1235 I
Methcathinone............................ 1237 I
Naphyrone................................ 1258 I
N-Ethylamphetamine....................... 1475 I
JWH-250 (1-Pentyl-3-(2- 6250 I
methoxyphenylacetyl) indole).
SR-18 (Also known as RCS--8) (1- 7008 I
Cyclohexylethyl-3-(2-
methoxyphenylacetyl) indole).
APINACA and AKB48 N-(1-Adamantyl)-1- 7048 I
pentyl-1H-indazole-3-carboxamide.
JWH-081 (1-Pentyl-3-(1-(4- 7081 I
methoxynaphthoyl) indole).
SR-19 (Also known as RCS-4) (1-Pentyl-3- 7104 I
[(4-methoxy)-benzoyl] indole.
[[Page 10358]]
JWH-018 (also known as AM678) (1-Pentyl-3- 7118 I
(1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1- 7122 I
naphthoyl) indole).
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I
tetramethylcyclopropyl)methanone.
JWH-203 (1-Pentyl-3-(2- 7203 I
chlorophenylacetyl) indole).
Ibogaine................................. 7260 I
Lysergic acid diethylamide............... 7315 I
Marihuana Extract........................ 7350 I
Marihuana................................ 7360 I
Tetrahydrocannabinols.................... 7370 I
Mescaline................................ 7381 I
JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I
naphthoyl) indole).
3,4-Methylenedioxymethamphetamine........ 7405 I
5-Methoxy-N-N-dimethyltryptamine......... 7431 I
Psilocyn................................. 7438 I
4-Methyl-alphapyrrolidinopropiophenone (4- 7498 I
MePPP).
MDPV (3,4-Methylenedioxypyrovalerone).... 7535 I
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone................................. 7541 I
Pentylone................................ 7542 I
Codeine-N-oxide.......................... 9053 I
Desomorphine............................. 9055 I
Dihydromorphine.......................... 9145 I
Heroin................................... 9200 I
Morphine-N-oxide......................... 9307 I
Normorphine.............................. 9313 I
Tilidine................................. 9750 I
Alpha-methylfentanyl..................... 9814 I
Acetyl Fentanyl (N-(1-phenethylpiperidin- 9821 I
4-yl)-N-phenylacetamide).
Methamphetamine.......................... 1105 II
Phenmetrazine............................ 1631 II
Methylphenidate.......................... 1724 II
Amobarbital.............................. 2125 II
Pentobarbital............................ 2270 II
Secobarbital............................. 2315 II
Glutethimide............................. 2550 II
Phencyclidine............................ 7471 II
4-Anilino-N-phenethyl-4-piperidine (ANPP) 8333 II
Norfentanyl.............................. 8366 II
Phenylacetone............................ 8501 II
Codeine.................................. 9050 II
Dihydrocodeine........................... 9120 II
Diphenoxylate............................ 9170 II
Ecgonine................................. 9180 II
Ethylmorphine............................ 9190 II
Hydrocodone.............................. 9193 II
Levorphanol.............................. 9220 II
Meperidine............................... 9230 II
Meperidine intermediate-B................ 9233 II
Meperidine intermediate-C................ 9234 II
Methadone intermediate................... 9254 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).
Morphine................................. 9300 II
Thebaine................................. 9333 II
14-Hydroxmorphone........................ 9665 II
Noroxymorphone........................... 9668 II
Sufentanil............................... 9740 II
Fentanyl................................. 9801 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
sale to research facilities for drug testing and analysis. In reference
to drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols) the
company plans to import a synthetic cannabidiol and a synthetic
tetrahydrocannabinol. No other activities for these drug codes are
authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-03381 Filed 2-18-21; 8:45 am]
BILLING CODE 4410-09-P
